News

The ongoing phase III trial is evaluating the drug in the treatment of 332 Chinese patients. According to Idenix, mainland China has the largest population affected by the

Currently marketed in Japan, Glufast is an insulin secretagogue that lowers post-meal glucose levels by improving the body’s own ability to produce insulin. Glufast has undergone extensive clinical

The acquisition is a strategic move by Sanofi-Aventis designed to develop its business in Central and Eastern Europe. Zentiva, which achieved sales in 2005 of E410 million, has

In a license agreement with the University’s technology transfer company, Isis Innovation, Geron receives a worldwide exclusive license for pioneering work by Oxford scientists who derived dendritic cells

The agreement with Inex Pharmaceuticals provides access to fundamental liposome delivery technology for systemic RNAi therapeutics. The agreement with the Massachusetts Institute of Technology (MIT) provides access to

The company has already won approval for a capsule form of the drug and Gerald Proehl, president and CEO of Santarus, explained that the company would not immediately

The vaccine combines antigens for protection against five important childhood diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B and hemophilus influenza type b, one of the leading causes

Alnylam and its collaborators at Protiva Biotherapeutics, demonstrated silencing in primates of the gene for apolipoprotein B (apoB), a protein involved in cholesterol metabolism, with clinically significant efficacy

The letter contains concerns and observations that must be satisfied prior to achieving approval, including a request for additional clinical trial work. If the company does need to